================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 14, 2004
Kewaunee Scientific Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-5286 38-0715562
---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
2700 West Front Street
Statesville, North Carolina 28677
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 704-873-7202
N/A
------------------------------------------------------------
(Former name or former address if changed since last report)
================================================================================
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Subject Matter
99.1 Press Release dated June 14, 2004, of Kewaunee Scientific
Corporation, announcing its fourth quarter and fiscal year-end
earnings.
Item 12. Results of Operations and Financial Condition.
On June 14, 2004 Kewaunee Scientific Corporation (the
"Company") issued a Press Release announcing its fourth
quarter and year-end earnings. The Press Release is
incorporated herein by reference, and is included as Exhibit
99.1 to this Current Report on Form 8-K.
This information shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act"), or otherwise subject to the liability of that
section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in
such filing.
Exhibit 99.1 to this report contains information regarding
certain non-recurring items incurred by the Company. For
comparative purposes, following the disclosure of certain
financial measures in Exhibit 99.1 that include the applicable
non-recurring items, the Company has reported the impact on
net earnings resulting from the non-recurring items, which
additional information constituting a "non-GAAP financial
measure" as defined in Item 10 of Regulation S-K of the
Securities Exchange Act of 1934, as amended. The Company has
included this additional information because it believes that
the disclosure of such information facilitates the comparison
of the Company's current results of operations to prior
periods.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
(Registrant)
Kewaunee Scientific Corporation
Date: June 14, 2004 By: /s/ D. Michael Parker
-------------------------------------
Senior Senior Vice President, Finance
Chief Financial Officer
3